Alnylam Pharmaceuticals, Inc. Financial Ratios — ALNY Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-41.74	-84.12	-44.13	-59.74	-26.36	-37.54	-36.54	-49.63	-64.66	-69.92	-106.31	- -	- -	- -	73.28
Return on Assets (%)	-17.08	-37.23	-25.2	-48.05	-23.52	-30.96	-30.14	-42.67	-44.64	-29.58	-24.19	-31.47	-11.94	-6.89	6.82
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.59
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	28.39
Gross Margin (%)	100	100	100	100	100	100	100	97.59	88.6	84.16	83.4	83.73	83.02	85.62	81.64
EBITDA Margin (%)	-60.05	-81.72	-175.36	-340.75	-673.91	-868.25	-542.96	-1,067.21	-402.76	-152.99	-73.31	-71.39	-12.48	-5.35	15
Operating Margin (%)	-66.24	-95.27	-197.05	-364.34	-720.27	-900.33	-556.2	-1,087.56	-427.5	-168.09	-83.93	-75.68	-15.43	-7.87	13.51
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.29
Pretax Margin (%)	-69.66	-174.73	-194.88	-792.32	-705.83	-869.63	-545.95	-1,015.48	-402.85	-173.6	-100.93	-108.63	-23.71	-16.79	8.7
Profit Margin (%)	-69.66	-158.88	-189.17	-712.79	-705.83	-869.63	-545.95	-1,016.58	-403.24	-174.15	-101.01	-109.04	-24.08	-12.37	8.45
Net Income to Common Margin (%)	-69.66	-158.88	-189.17	-712.79	-705.83	-869.63	-545.95	-1,016.58	-403.24	-174.15	-101.01	-109.04	-24.08	-12.37	8.45
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.91
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-41.74	-84.12	-44.13	-59.74	-26.36	-37.54	-36.54	-49.63	-64.66	-69.92	-106.31	- -	- -	- -	73.28

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	150	30	30	304	521	998	1,320	1,305	1,296	1,278
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	28	37	41	42	42	42	46
LT Debt	- -	- -	- -	- -	- -	150	30	30	276	484	957	1,278	1,264	1,254	1,233
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.37	-0.06	-0.04	-0.34	-0.69	-1.61	-1.78	-5.72	-10.78	2.29
Net Debt/EBITDA	1.41	0.94	0.64	0.44	0.65	0.11	1.26	0.49	0.62	0.4	0.23	-0.2	-0.91	-0.48	-1.17
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.35	-0.06	-0.04	-0.32	-0.63	-1.41	-1.68	-4.63	-7.33	2.55
Net Debt/EBIT	1.28	0.81	0.57	0.41	0.61	0.1	1.23	0.48	0.58	0.37	0.2	-0.19	-0.74	-0.33	-1.29
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-8.92	-4.33	-4.75	-1.88	-0.85	2.21
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-9.76	-4.86	-5.21	-2.4	-1.09	1.97
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	-9.8	-4.95	-5.03	-2.33	-1.25	1.99
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	84	143	156	121	142	253
Common Equity/Total Assets	41.86	46.62	64.29	86.72	91.22	72.87	88.55	82.67	60.07	29.83	16.14	-4.46	-5.76	1.58	15.89
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	19.19	47.66	162.71	- -	- -	1,869.43	156.22
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	14.02	1.67	2.25	15.85	31.5	60.35	110	116.51	92.01	59.63
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	11.53	14.22	26.27	36.04	33	29.58	24.82
Total Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	21.12	51.29	169.6	-834.42	-591.63	1,931.86	161.99
Total Debt/Capital (%)	- -	- -	- -	- -	- -	14.02	1.67	2.25	17.44	33.9	62.91	113.62	120.34	95.08	61.83
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	12.69	15.3	27.38	37.23	34.08	30.57	25.74
Net Debt to Equity	-59.52	-38.35	-19.67	-8.03	-14.3	-4.74	-34.84	-29.97	-38.03	-30.04	-24.53	-95.15	-94.31	86.74	-82.3
Net Debt/Capital (%)	-147.02	-62.2	-24.48	-8.73	-16.69	-4.98	-53.46	-42.79	-45.78	-29.33	-18.84	50.92	76.49	14.67	-158.28
EBITDA	-50	-55	-83	-172	-277	-409	-488	-799	-885	-754	-619	-741	-228	-120	557
EBITDA-CapEx	-51	-63	-87	-181	-290	-474	-592	-926	-1,025	-824	-695	-813	-290	-154	499
Operating Income (Loss)	-55	-64	-93	-184	-296	-425	-500	-815	-939	-828	-709	-785	-282	-177	502

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.81	2.54	4.56	7.31	17.4	4.76	11.72	6.04	4.36	3.2	3.5	2.86	2.52	2.27	1.98
Current Ratio	1.88	2.6	4.72	7.83	17.8	5.1	12.23	6.69	4.87	4.47	4.04	3.51	3.08	2.78	2.76
Quick Ratio	1.83	2.54	4.64	7.73	17.53	4.94	11.96	6.14	4.48	4.23	3.79	3.16	2.86	2.61	2.51
CFO/Avg Current Liab	-0.95	-1.79	-1.34	-2.22	-2.4	-3.18	-2.77	-3.48	-1.05	-1.31	-1	-0.74	0.12	-0.01	0.4
Common Equity/Total Assets	41.86	46.62	64.29	86.72	91.22	72.87	88.55	82.67	60.07	29.83	16.14	-4.46	-5.76	1.58	15.89
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	19.19	47.66	162.71	- -	- -	1,869.43	156.22
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	14.02	1.67	2.25	15.85	31.5	60.35	110	116.51	92.01	59.63
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	11.53	14.22	26.27	36.04	33	29.58	24.82
Total Debt/Equity (%)	- -	- -	- -	- -	- -	16.3	1.7	2.3	21.12	51.29	169.6	-834.42	-591.63	1,931.86	161.99
Total Debt/Capital (%)	- -	- -	- -	- -	- -	14.02	1.67	2.25	17.44	33.9	62.91	113.62	120.34	95.08	61.83
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	11.88	1.5	1.91	12.69	15.3	27.38	37.23	34.08	30.57	25.74
CFO/Total Liabilities	-53.12	-75.33	-45.72	-115.57	-155.29	-89.82	-167.67	-206.21	-29.11	-25.72	-21	-14.61	2.57	-0.2	12.55
CFO/CapEx	-67.44	-13.85	-17.14	-18.48	-14.61	-4.77	-3.67	-4.43	-1.99	-8.74	-8.4	-7.51	1.67	-0.24	8.93
Altman's Z-Score	-0.76	1.1	14.34	30.32	38.43	3.24	31.96	12.82	5.41	1.97	2.2	2.39	1.87	2.96	7.38

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	33.65	84.89	21.68	2.29	1.7	2.98	3.14	2.84	7.11	6.78	5.61	4.75	6.46	6.13	6.28
Days Sales Outstanding	10.85	4.3	16.84	159.49	214.2	122.41	116.38	128.55	51.3	53.85	65.06	76.79	56.47	59.51	58.13
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.15	0.62	1.19	1.73	1.57	2.85	3.86	8.46
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	2,437.52	585.58	307.59	210.4	232.78	128.23	94.62	43.15
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.59	1.05	1.9	2.41	2.47	3.52	4.35	6.72
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	621.24	348.79	191.81	151.24	148.06	103.6	83.99	54.3
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	1,944.82	288.09	169.63	124.21	161.51	81.1	70.13	46.98
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-2,308.97	-534.28	-253.74	-145.33	-155.98	-71.76	-35.11	14.97
Inventories	- -	- -	- -	- -	- -	- -	- -	24	56	75	86	129	89	79	83
Raw Materials	- -	- -	- -	- -	- -	- -	- -	9	15	63	15	22	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	15	38	16	101	114	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	3	13	7	26	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	89	79	83

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	348	958	4,099	7,489	8,010	3,218	12,663	7,377	12,921	15,132	20,380	29,451	24,078	30,424	52,639
- Cash & Cash Equivalents	70	51	53	75	181	194	645	420	547	497	820	866	813	966	1,657
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	150	30	30	304	521	998	1,320	1,305	1,296	1,278
Enterprise Value	202	835	3,853	6,792	6,930	2,741	11,002	6,323	11,688	13,779	18,942	28,579	22,944	29,026	51,009
Total Capital	118	134	270	936	1,265	1,070	1,796	1,332	1,743	1,537	1,586	1,162	1,085	1,363	2,068
Total Debt/Capital (%)	- -	- -	- -	- -	- -	14.02	1.67	2.25	17.44	33.9	62.91	113.62	120.34	95.08	61.83
Total Debt / EV	- -	- -	- -	- -	- -	0.05	- -	- -	0.03	0.04	0.05	0.05	0.06	0.04	0.03
EV/Sales	2.44	12.52	81.68	134.33	168.62	58.12	122.36	84.41	53.19	27.96	22.44	27.55	12.55	12.91	13.73
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	91.54
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	101.7
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100.96	301.57	66.3
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	79.26	222.37	61.6
Diluted Market Cap	346	918	3,958	7,205	7,907	3,205	11,505	7,334	12,584	14,945	20,087	28,919	23,908	30,038	53,557
Diluted Enterprise Value	275	866	3,905	7,130	7,726	3,161	10,890	6,944	12,341	14,969	20,265	29,373	24,401	30,367	53,178
EV per Share	4.72	15.91	60.44	87.98	81.44	31.89	110.39	62.49	104.19	118.35	157.62	230.61	182.4	224.49	385.34
TTM Sales	83	67	47	51	41	47	90	75	220	493	844	1,037	1,828	2,248	3,714
TTM EBITDA	-50	-55	-83	-172	-277	-409	-488	-799	-885	-754	-619	-741	-228	-120	557
TTM Operating Income	-55	-64	-93	-184	-296	-425	-500	-815	-939	-828	-709	-785	-282	-177	502
TTM Cash Flow to Firm	-87	-116	-69	-166	-189	-308	-383	-563	-278	-530	-499	-385	227	96	769
TTM Free Cash Flow to Firm	-86	-107	-65	-157	-176	-243	-279	-436	-138	-460	-422	-313	289	131	828

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-4.03	-8.56	-61.22	-45.99	-44.88	-13.18	-41.3	-16.83	-91.01	-27.44	-35.53	-61.63	143.71	1,156.85	91.9
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	101.7
Enterprise Value	202	835	3,853	6,792	6,930	2,741	11,002	6,323	11,688	13,779	18,942	28,579	22,944	29,026	51,009
Low Price	5.88	8.33	18.61	47.03	71.14	31.38	35.98	60.27	65.81	84.97	124	117.58	148.1	141.98	205.87
EV/Sales	2.44	12.52	81.68	134.33	168.62	58.12	122.36	84.41	53.19	27.96	22.44	27.55	12.55	12.91	13.73
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	91.54
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	166.04
Price/Earnings Average	-6.45	-6.8	-27.68	-15.15	-30.74	-12.62	-14.84	-13.36	-10.46	-17.63	-23.32	-18.81	-54.58	-97.64	145.24
Price/Earnings High	-9.08	-10.14	-46.89	-23.2	-40.54	-20.45	-27.23	-20.34	-15.5	-22.42	-29.45	-26.14	-68.77	-139.69	206.92
Price/Earnings Low	-4.32	-3.95	-12.84	-9.69	-20.6	-6.55	-6.64	-7.96	-8.11	-11.38	-17.22	-12.65	-42.02	-65.16	85.96
Price/Book Value	2.95	7.15	15.16	8	6.33	3.5	7.17	5.67	8.98	14.89	34.65	-186.13	-109.13	453.5	66.7
Price/Book Value Average	3.17	5.62	9.46	6.06	7.14	5.65	4.54	7.86	6.62	15.07	34.3	-136.94	-109.68	410.04	58.35
Price/Book Value High	4.47	8.37	16.03	9.28	9.42	9.15	8.33	11.97	9.8	19.17	43.32	-190.3	-138.19	586.63	83.12
Price/Book Value Low	2.13	3.26	4.39	3.88	4.79	2.93	2.03	4.68	5.13	9.73	25.34	-92.09	-84.44	273.63	34.53
Price/Tangible Book Value	2.96	7.15	15.16	8	6.33	3.5	7.17	5.67	8.98	14.89	34.65	-186.13	-109.13	453.5	66.7
Price/Tangible Book Value Average	3.18	5.62	9.46	6.06	7.14	5.65	4.54	7.86	6.62	15.07	34.3	-136.94	-109.68	410.04	58.35
Price/Tangible Book Value High	4.48	8.37	16.03	9.28	9.42	9.15	8.33	11.97	9.8	19.17	43.32	-190.3	-138.19	586.63	83.12
Price/Tangible Book Value Low	2.13	3.26	4.39	3.88	4.79	2.93	2.03	4.68	5.13	9.73	25.34	-92.09	-84.44	273.63	34.53
Price/Sales	4.18	13.75	83.91	142.5	192.4	67.96	127.96	97.91	57.26	30.32	23.79	27.88	13.08	13.36	14.03
Price/Sales Average	4.49	10.81	52.36	107.99	216.98	109.77	80.99	135.86	42.18	30.7	23.55	20.51	13.14	12.08	12.27
Price/Sales High	6.32	16.11	88.7	165.37	286.13	177.88	148.68	206.78	62.51	39.04	29.74	28.5	16.56	17.28	17.48
Price/Sales Low	3.01	6.28	24.29	69.09	145.39	56.96	36.24	80.93	32.72	19.82	17.4	13.79	10.12	8.06	7.26
Price/Cash Flow	-3.97	-7.94	-57.64	-43.5	-41.81	-10.42	-30.06	-13.04	-45.2	-24.3	-31.3	-53.43	229.54	-3,613.76	99.4
Price/Cash Flow Average	-4.27	-6.24	-35.97	-32.96	-47.15	-16.82	-19.02	-18.09	-33.29	-24.6	-30.99	-39.31	230.71	-3,267.5	86.95
Price/Cash Flow High	-6.01	-9.3	-60.94	-50.48	-62.17	-27.26	-34.92	-27.53	-49.34	-31.29	-39.13	-54.62	290.68	-4,674.65	123.87
Price/Cash Flow Low	-2.86	-3.62	-16.68	-21.09	-31.59	-8.73	-8.51	-10.78	-25.83	-15.89	-22.89	-26.43	177.6	-2,180.45	51.46
Price/Free Cash Flow Average	-4.33	-6.72	-38.2	-34.85	-50.61	-21.29	-26.14	-23.36	-67.04	-27.78	-35.18	-45.35	144.44	1,046	80.39
Price/Free Cash Flow High	-6.1	-10.02	-64.71	-53.37	-66.74	-34.5	-47.99	-35.55	-99.35	-35.33	-44.42	-63.01	181.98	1,496.46	114.53
Price/Free Cash Flow Low	-2.91	-3.91	-17.72	-22.3	-33.91	-11.05	-11.7	-13.91	-52	-17.94	-25.98	-30.49	111.19	698.01	47.58
EV/Sales Average	3.67	10.51	53.1	110.76	215.42	109.29	82.3	131.45	42.2	31.13	24.11	21.32	13.51	12.38	12.3
EV/Sales High	5.52	16.05	90.73	170.4	285.47	177.67	156.8	202.78	63.08	39.58	30.39	29.46	16.95	17.65	17.56
EV/Sales Low	2.19	5.78	24.02	70.32	142.89	56.26	33.04	76.2	32.49	20.12	17.86	14.48	10.46	8.31	7.24
EV/EBITDA Average	-6.12	-12.86	-30.28	-32.5	-31.97	-12.59	-15.16	-12.32	-10.48	-20.35	-32.88	-29.87	-108.25	-231.57	81.95
EV/EBITDA High	-9.2	-19.64	-51.74	-50.01	-42.36	-20.46	-28.88	-19	-15.66	-25.87	-41.45	-41.27	-135.82	-330.12	117.04
EV/EBITDA Low	-3.64	-7.08	-13.7	-20.64	-21.2	-6.48	-6.09	-7.14	-8.07	-13.15	-24.36	-20.29	-83.83	-155.44	48.23
EV/EBIT Average	-5.55	-11.04	-26.95	-30.4	-29.91	-12.14	-14.8	-12.09	-9.87	-18.52	-28.72	-28.18	-87.51	-157.38	91.05
EV/EBIT High	-8.34	-16.85	-46.04	-46.77	-39.63	-19.73	-28.19	-18.65	-14.75	-23.55	-36.2	-38.93	-109.8	-224.36	130.03
EV/EBIT Low	-3.3	-6.07	-12.19	-19.3	-19.84	-6.25	-5.94	-7.01	-7.6	-11.97	-21.28	-19.14	-67.77	-105.64	53.58
Last Price	8.15	18.25	64.3	97	94.14	37.44	127.05	72.91	115.17	129.97	169.58	237.65	191.41	235.31	397.65
High Price	12.34	21.38	67.97	112.57	140	98	147.63	153.99	125.72	167.33	212	242.97	242.39	304.39	495.55
Enterprise Value Average	304	702	2,504	5,600	8,853	5,154	7,400	9,846	9,274	15,344	20,354	22,122	24,693	27,839	45,667
Enterprise Value High	457	1,071	4,279	8,616	11,732	8,379	14,098	15,190	13,861	19,506	25,656	30,564	30,984	39,685	65,220
Enterprise Value Low	181	386	1,133	3,556	5,872	2,653	2,971	5,708	7,140	9,917	15,080	15,025	19,123	18,687	26,873

Shares Outstanding	43	52	64	77	85	86	100	101	112	116	120	124	126	129	132
Diluted Weighted Avg Shares	42	50	62	74	84	86	91	101	109	115	118	122	125	128	135
Basic Weighted Avg Shares	42	50	62	74	84	86	91	101	109	115	118	122	125	128	131
Revenue per Share	1.95	1.33	0.77	0.68	0.49	0.55	0.99	0.74	2.01	4.29	7.13	8.53	14.64	17.61	28.35
EBITDA per Share	-1.17	-1.08	-1.34	-2.32	-3.3	-4.78	-5.39	-7.95	-8.1	-6.56	-5.23	-6.09	-1.83	-0.94	4.25
Operating Income per Share	-1.29	-1.26	-1.51	-2.48	-3.52	-4.96	-5.52	-8.1	-8.6	-7.2	-5.98	-6.45	-2.26	-1.39	3.83
Basic EPS, GAAP	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.39
Basic EPS from Cont Ops	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.39
Diluted EPS, GAAP	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.33
Diluted EPS from Cont Ops	-1.36	-2.11	-1.45	-4.85	-3.45	-4.79	-5.42	-7.57	-8.11	-7.46	-7.2	-9.3	-3.52	-2.18	2.33
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.05	-2.3	-1.12	-2.23	-2.25	-3.59	-4.23	-5.59	-2.55	-5.35	-5.42	-4.45	0.83	-0.07	4
Free Cash Flow per Basic Share	-2.08	-2.47	-1.18	-2.35	-2.41	-4.35	-5.38	-6.85	-3.83	-5.96	-6.06	-5.04	0.34	-0.33	3.55
Cash & Equivalents per Share	3.43	2.34	3.86	9.02	12.7	7.29	16.96	10.72	13.69	16.1	20.27	17.69	19.39	20.84	21.97
Book Value per Share	2.76	2.55	4.24	12.13	14.86	10.71	17.72	12.87	12.82	8.73	4.89	-1.28	-1.75	0.52	5.96
Tangible Book Value per Share	2.76	2.55	4.24	12.13	14.86	10.71	17.72	12.87	12.82	8.73	4.89	-1.28	-1.75	0.52	5.96

Alnylam Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)